Cargando…
Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies
The delta isoform of the p110 catalytic subunit (p110δ) of phosphoinositide 3-kinase is expressed primarily in hematopoietic cells and plays an essential role in B-cell development and function. Studies employing mice lacking a functional p110δ protein, as well as the use of highly-selective chemica...
Autores principales: | Puri, Kamal D., Gold, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3425960/ https://www.ncbi.nlm.nih.gov/pubmed/22936933 http://dx.doi.org/10.3389/fimmu.2012.00256 |
Ejemplares similares
-
Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome
por: Condliffe, Alison M., et al.
Publicado: (2018) -
Exhaustion of the CD8(+) T Cell Compartment in Patients with Mutations in Phosphoinositide 3-Kinase Delta
por: Wentink, Marjolein W. J., et al.
Publicado: (2018) -
Dual inhibition of phosphoinositide 3-kinases delta and gamma reduces chronic B cell activation and autoantibody production in a mouse model of lupus
por: Olayinka-Adefemi, Folayemi, et al.
Publicado: (2023) -
The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions
por: Pauls, Samantha D., et al.
Publicado: (2012) -
Dose-Dependent Suppression of Cytokine production from T cells by a Novel Phosphoinositide 3-Kinase Delta Inhibitor
por: Way, Emily E., et al.
Publicado: (2016)